SG Americas Securities
AST

SG Americas Securities’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

SG Americas Securities’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-13,800
Closed -$31K – 3777
2017
Q4 		$31K Buy
+13,800
New +$34.9K ﹤0.01% 3028
2017
Q3 		– Sell
-16,150
Closed -$57K – 3938
2017
Q2 		$57K Buy
16,150
+4,915
+44% +$16.2K ﹤0.01% 3016
2017
Q1 		$38K Buy
+11,235
New +$43.7K ﹤0.01% 3141
2016
Q3 		– Sell
-22,117
Closed -$53K – 3645
2016
Q2 		$53K Buy
+22,117
New +$80K ﹤0.01% 2451
2015
Q4 		– Sell
-10,735
Closed -$42K – 3259
2015
Q3 		$42K Buy
+10,735
New +$49.3K ﹤0.01% 1983

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

SG Americas Securities's AST Position: Q1 2018 in Review

SG Americas Securities sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2018, closing a stake of 13,800 shares — an estimated $31K sold.

SG Americas Securities first reported a position in AST in Q3 2015 and held it in 5 quarters. The position peaked at $57K in Q2 2017. 72 funds tracked by Wall St. Rank hold AST as of Q1 2018.

  • SG Americas Securities reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2018 after selling out during the quarter.
  • SG Americas Securities sold 13,800 Asterias Biotherapeutics Inc. Series A shares in Q1 2018, an estimated $31K.
  • SG Americas Securities first reported a position in Asterias Biotherapeutics Inc. Series A in Q3 2015 and held it in 5 quarters.
  • SG Americas Securities's Asterias Biotherapeutics Inc. Series A position peaked at $57K in Q2 2017.
  • 72 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2018.

Based on SG Americas Securities's 13F filing for Q1 2018, filed 3 May 2018.